FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/05/2022
Voltar para busca
Dado oficial do USPTO
MABXMISE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MABXMISE
ST13
US500000079292587Classe
1, 5, 41, 42, 44
Pedido
79292587
Registro
6549567
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
02/09/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 41, 42, 44
Data de depósito
27/01/2020
Data de registro
09/11/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/11/2021
Última transação
02/09/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FR
Examinador
MASULLO, MARCO
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
P. P. (pessoa física)
Representantes
Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry and sciencenot for medical usebiochemical catalystsbiochemical reagents used for non-medical purposesbiochemical preparations for scientific purposesbiological preparations for use in industry and science; proteins for industrial usein raw materials form for scientific and medical research; diagnostic preparations used in science; diagnostic reagents and preparationsexcept for medical or veterinary use; immunohistochemistry detection kits consisting of mouse secondary reagentsDAB chromogensDAB buffersperoxidase blocking reagenthematoxylinfor anatomic pathology purposes in the medical diagnostics industry
Classe 5
Medicated skin care preparations; medicated skin care preparations for veterinary use; diagnostic preparations for veterinary purposeschemical reagents for medical or veterinary purposes; proteins for medical or veterinary useprotein arrays for medical diagnosis purposes; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids
Classe 41
Educational servicesproviding tutorial sessionspanel discussionsnon-downloadable webinarsseminarstraining in the fields of pharmaceuticals and biotechnology; publishing of booksmanualsmagazinescomputer data intended for use on a computer or telephone network; electronic publishing servicespublication of text and graphic works of others on CD-ROMs in the fields of pharmaceuticals and biotechnology; organizing and conducting colloquiumsconferences and congresses in the fields of pharmaceuticals and biotechnology; organization of exhibitions for cultural or educational purposes; organization of events for cultural purposes; organizing events in the fields of pharmaceuticals and biotechnology for educational purposes
Classe 42
Scientific and industrial research in the fields of chemistrybiochemistrybiotechnology and biology; computer programmingdesigndevelopmentrentalupdating and maintenance of software; engineering services in the nature of the provision of expert reports in the field of chemistrybiochemistrybiotechnologies and biology; technical adviceconsultation and information all in the fields of biochemistrybiotechnologies and biologytechnical support and advice for drawing updeveloping and implementing protein chemistryprotein biochemistrybiotechnologies and protein biology methodsprotocolsprocedures; material testingtesting of chemicalbiochemicalbiotechnology and biological materials and substances; research services in the chemicalbiochemicalbiotechnological and biological fields provided in laboratories; therapeutic strategies research and development servicesresearch and development in the pharmaceutical and biotechnology fields
Classe 44
Medical services; veterinary services; medical analysis services in relation to the treatment of individualsx-ray examinations for medical purposesmedical testing of bloodmedical testing of urinebloodhair follicles and breathmedical imaging servicesmedical testing for diagnostic or treatment purposes; DNA screening for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/04/2022
FIMP
FINAL DISPOSITION PROCESSED
27/04/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/02/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/12/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/12/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/12/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/12/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/12/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/12/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
16/12/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/12/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/12/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/08/2021
PUBO
PUBLISHED FOR OPPOSITION
24/08/2021
GPNX
NOTIFICATION PROCESSED BY IB
22/08/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/08/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/04/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
26/04/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/04/2021
GNFR
FINAL REFUSAL E-MAILED
01/04/2021
CNFR
FINAL REFUSAL WRITTEN
01/04/2021
DOCK
ASSIGNED TO EXAMINER
02/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/11/2020
RFNT
REFUSAL PROCESSED BY IB
19/10/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/09/2020
RFRR
REFUSAL PROCESSED BY MPU
28/09/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/09/2020
CNRT
NON-FINAL ACTION WRITTEN
08/09/2020
MAFR
APPLICATION FILING RECEIPT MAILED
01/09/2020
DOCK
ASSIGNED TO EXAMINER
28/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/08/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/08/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MABXMISE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.